Search
RELVAR ELLIPTA 184 µg / 22 µg, Poudre pour inhalation
Details
| --- | Description |
|---|---|
| Pack | Boite de 30 doses |
| Strength (Dosage) | 184 µg | 22 µg |
| Laboratory | GSK MAROC |
| Ingredients | Vilantérol I Fluticasone |
| Therapeutic class | Antiasthmatique, bêta-2-sympathomimétique avec corticostéroïde |
| ATC code | R03AK10 |
| PPH | $28.50 |
| PPV | $43.00 |
| Refundable | Yes |
| Refund base | $43.00 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Asthme Relvar Ellipta est indiqué en traitement continu de l'asthme chez les adultes et les adolescents âgés de 12 ans et plus, dans les situations où l’utilisation d'un médicament associant un corticoïde par voie inhalée et un bronchodilatateur bêta2-agoniste de longue durée d'action est justifiée : - chez des patients insuffisamment contrôlés par une corticothérapie inhalée et la prise d'un bronchodilatateur bêta2-agoniste à action rapide et de courte durée par voie inhalée "à la demande". - chez les patients contrôlés par l'administration d'une corticothérapie inhalée associée à un traitement continu par bêta-2 agoniste de longue durée d'action par voie inhalée. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem